Pfizer-BioNTech will produce their Covid-19 vaccine in South Africa starting in 2022. The doses will be distributed exclusively for African nations.
When fully operational, the companies said annual vaccine production would exceed 100 million doses, to be distributed exclusively within African countries. In a statement, the companies said they signed a letter of intent with the Biovac Institute in Cape Town to transfer technology, install equipment, and develop manufacturing capability. The raw material for the vaccines will be transported from Europe and the first doses will be produced in 2022.
Read MoreThere have been steady calls from countries including India and South Africa to waive the intellectual property rights on vaccine technology -- part of ongoing negotiations at the World Trade Organization.The vaccine rollout on the continent has been plagued by a shortage of doses, much of which are supplied by the global vaccine distribution initiative COVAX.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Vaccine Partner BioNTech Inks Cancer DealBioNTech, the company behind one of the Covid-19 vaccines, has agreed to acquire a U.S. manufacturing plant from a unit of Gilead Sciences in a deal aimed at strengthening its core business of developing cutting-edge cancer therapies
Read more »
South Africa’s Biovac to manufacture Pfizer-BioNTech vaccines for AfricaThe South African firm will begin producing the Pfizer-BioNTech Covid-19 vaccine in 2022 and all will be marked for distribution for countries under the African Union.
Read more »
Third Covid Wave Upends Fragile South Africa, a Warning for Developing WorldThe pandemic is pummeling the country’s economy, adding to the longstanding frustrations of an impoverished majority. The resulting unrest shows how difficult it will be for many emerging economies to recover from the coronavirus.
Read more »
Dr. Vin Gupta encourages J&J vaccine recipients to get a Pfizer or Moderna boosterDr. Vin Gupta explains why he’s encouraging patients who received the single-shot J&J Covid vaccine to get a Pfizer or Moderna booster shot.
Read more »
How Well Does The Pfizer Vaccine Protect Against The Delta Variant? Here’s What We KnowI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
South Africa’s Biovac to manufacture Pfizer-BioNTech vaccines for AfricaThe South African firm will begin producing the Pfizer-BioNTech Covid-19 vaccine in 2022 and all will be marked for distribution for countries under the African Union.
Read more »